Are there any related-party or family relationships disclosed for Splash Beverage’s new director?

The company states that Francis Knuettel II has no family relationships with any director or executive officer. It also reports no transactions involving him that require disclosure under Item 404(a) of Regulation S-K, indicating no related-party dealings are identified.

Splash Beverage adds Francis Knuettel to board

Splash Beverage Group appointed Francis Knuettel II to its Board of Directors, effective April 27, 2026.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

Splash Beverage Group appointed Francis Knuettel II to its Board of Directors, effective April 27, 2026. He will also serve on the Audit Committee, Compensation Committee, and the Corporate Governance and Nominating Committee.

Knuettel brings experience as a senior executive at early-stage public companies. He previously served as Chief Financial Officer of Pelthos Therapeutics Inc. from June 2022 to April 2026, Chief Executive Officer of Pelthos from July 2023 to July 2025, and as a director of Pelthos from August 2024 to July 2025. He also led Unrivaled Brands as Chief Executive Officer and director from December 2020 to March 2022.

The company states there are no arrangements or understandings with other parties regarding his appointment, no family relationships with existing directors or executive officers, and no related-party transactions requiring disclosure under Regulation S-K Item 404(a).

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Key Figures

Board appointment effective date: April 27, 2026 Board committees: 3 committees Pelthos CFO tenure: June 2022 to April 2026 +2 more

5 metrics

Board appointment effective date April 27, 2026 Date Francis Knuettel II joined the Board

Board committees 3 committees Audit, Compensation, Corporate Governance and Nominating

Pelthos CFO tenure June 2022 to April 2026 Francis Knuettel II at Pelthos Therapeutics Inc.

Pelthos CEO tenure July 2023 to July 2025 Chief Executive Officer role at Pelthos

Unrivaled Brands CEO tenure December 2020 to March 2022 Chief Executive Officer and director at Unrivaled Brands

Key Terms

Emerging growth company, Audit Committee, Compensation Committee, Corporate Governance and Nominating Committee, +2 more

6 terms

Emerging growth company regulatory

"Emerging growth company"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

Audit Committee financial

"appointed as a member of the Audit Committee, Compensation"

A company's audit committee is a small group of board members who act like independent inspectors for the firm's finances, overseeing how financial reports are prepared, monitoring internal controls, and managing the relationship with external auditors. Investors care because a strong audit committee reduces the risk of accounting errors, fraud, or misleading statements, making financial statements more trustworthy and helping protect shareholder value.

Compensation Committee financial

"Audit Committee, Compensation Committee and the Corporate Governance"

A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.

Corporate Governance and Nominating Committee financial

"Compensation Committee and the Corporate Governance and Nominating Committee"

A corporate governance and nominating committee is a group of independent board members who set rules for how a company is run and choose or vet candidates for the board and senior leadership. Think of them as the company’s rulebook authors and hiring panel for its top oversight team; their choices and policies influence management accountability, risk oversight and investor confidence, so investors watch them for signs of strong leadership and transparency.

Item 404(a) of Regulation S-K regulatory

"no transactions in which he has an interest requiring disclosure under Item 404(a) of Regulation S-K"

Item 5.02 regulatory

"Item 5.02 Departure of Directors or Certain Officers; Election of Directors"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Splash Beverage Group (SBEV) announce about its board of directors?

Splash Beverage Group appointed Francis Knuettel II to its Board of Directors, effective April 27, 2026. He joins as a new director with extensive experience in early-stage public companies and will serve on three key board committees.

Who is Francis Knuettel II, newly appointed to Splash Beverage Group (SBEV)?

Francis Knuettel II is an experienced CXO who has led early-stage public companies. He most recently served as CFO, CEO, and director at Pelthos Therapeutics Inc., and earlier was CEO and director of Unrivaled Brands, focusing on growth in dynamic sectors.

Which committees will Francis Knuettel II serve on at Splash Beverage Group (SBEV)?

Francis Knuettel II will serve on the Audit Committee, the Compensation Committee, and the Corporate Governance and Nominating Committee. These roles place him at the center of financial oversight, executive pay, and governance matters for Splash Beverage Group.

Was Francis Knuettel II’s appointment to the Splash Beverage (SBEV) board based on any special arrangements?

The filing states there are no arrangements or understandings between Francis Knuettel II and any other person regarding his appointment. This indicates the board selected him without contractual appointment rights or third-party nomination agreements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 04/27/2026 - 04:30 PM EDT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): April 27, 2026

SPLASH BEVERAGE GROUP, INC.

(Exact name of registrant as specified in its charter)

Nevada

001-40471

34-1720075

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

1314 East Las Olas Blvd, Suite 221

Fort Lauderdale, Florida 33301

(Address of principal executive offices)

Registrant’s telephone number, including area code: (954) 745-5815

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Common Stock, $0.001 par value		SBEV		NYSE American LLC
(Title of Each Class)		(Trading Symbol)		(Name of Each Exchange on Which Registered)

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (CFR §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (CFR §240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(a)

On April 27, 2026, the Board appointed Francis Knuettel II to serve on the Board, effective immediately.

Mr. Knuettel is a newly-appointed director of the Company. Francis Knuettel II has spent most of his career as a CXO in early-stage public companies – specializing in dynamic technology and life sciences companies – with a strong track record in growing organizations. Mr. Knuettel served as Chief Financial Officer of Pelthos Therapeutics Inc. [NYSE American: PTHS] from June 2022 to April 2026, as Chief Executive Officer of Pelthos from July 2023 to July 2025, and as a director of Pelthos from August 2024 to July 2025. Prior to that, from December 2020 to March 2022, he served as Chief Executive Officer and director of Unrivaled Brands.

Mr. Knuettel has also been appointed as a member of the Audit Committee, Compensation Committee and the Corporate Governance and Nominating Committee of the Board.

There are no arrangements or understandings between Mr. Knuettel and any other person pursuant to which he was appointed as a director. Mr. Knuettel has no family relationships with any director or executive officer of the Company, and there are no transactions in which he has an interest requiring disclosure under Item 404(a) of Regulation S-K.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: April 27, 2026

	SPLASH BEVERAGE GROUP, INC.

	By:	/s/ William Meissner
		William Meissner, President

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

3 documents